Build. Simulate. Analyse. Optimise. Visualise.

KerusCloud is a uniquely powerful revolutionary cloud-based study simulation platform that allows clinical development teams to explore multiple study design and analysis options in a virtual environment. Its use supports earlier data-driven design decisions to ensure that clinical studies are fully optimised statistically from the outset to maximise their chances of success.

Build

Build:

Integrate existing and emerging knowledge and data sources from the literature, clinical trial data, real-world data and expert opinion to build realistic synthetic patient populations.

Simulate

Simulate:

Sample these virtual populations to generate highly realistic study simulations in minutes for high numbers of scenarios.

Analyse-

Analyse:

Explore multiple fixed and adaptive study designs, analysis and decision-making strategies by applying different statistical analyses and decision criteria.

Optimise

Optimise:

Evaluate the suitability of different trial designs and data analysis methods guided by the quantified POS for each approach.

Visualise

Visualise:

View and share simulated outcomes with Probability of Success values using the interactive heatmap to quickly identify the design and analysis strategy most likely to deliver success.

Try It Out

Build. Simulate. Analyse. Optimise. Visualise.

KerusCloud is a uniquely powerful revolutionary cloud-based study simulation platform that allows clinical development teams to explore multiple study design and analysis options in a virtual environment. Its use supports earlier data-driven design decisions to ensure that clinical studies are fully optimised statistically from the outset to maximise their chances of success.

Build. Integrate existing and emerging knowledge and data sources from the literature, clinical trial data, real-world data and expert opinion to build realistic synthetic patient populations.

Simulate. Sample these virtual populations to generate highly realistic study simulations in minutes for high numbers of scenarios.

Analyse. Explore multiple fixed and adaptive study designs, analysis and decision-making strategies by applying different statistical analyses and decision criteria.

Optimise. Evaluate the suitability of different trial designs and data analysis methods guided by the quantified POS for each approach.

Visualise. View and share simulated outcomes with Probability of Success values using the interactive heatmap to quickly identify the design and analysis strategy most likely to deliver success.

Try It Out

01 / KerusCloud Virtual Population

01 | Generate Realistic Patient Populations

Create synthetic datasets for highly realistic virtual patient populations by extracting information as real world data or by pre-existing data models.

Find Out More

02 / KerusCloud Building Study Scenarios

02 | Build study scenarios

Construct parallel development scenarios using virtual patient populations following intuitive workflows.

Find Out More

03/ KerusCloud Simulation

03 | Cloud-based simulation

Select from a range of fixed and adaptive study designs as well as different statistical analysis options before running high numbers of complex study simulations in parallel in minutes using the intensive processing power of the cloud.

Try it Out

04 / Interactive Visualisation of Results

04 | Interactive visualisation of results

View, explore and share simulated scenario results to understand the interactions between multiple study parameters and their effect on outcomes.

Try it Out

05/ Identify the best design for real studies

05 | Identify the best design for real studies

Review results to select the optimal design and analysis options for real studies so they can answer relevant clinical questions, first time.

Find Out More

06 / Export Simulated Data

06 | Export Simulated Data

Export detailed reports containing simulated virtual populations, study designs, analyses and decision criteria for further exploration, validation or audit.

Find Out More

“The simulations were beautiful. They exploited the full potential of a historical data set to inform the design of our study. Options were ruled in or out and critical elements identified. This allowed us to simplify, enhance and de-risk the study design.”

Chief Medical Officer, Small BioTech, UK

“We were extremely pleased with the results of the work. Until Exploristics became involved we were struggling to come to conclusions about the utility of the biomarkers being evaluated. The results with Kerus provided our team with a solid understanding of the data allowing clear conclusions to be drawn.”

Senior Scientific Director, Respiratory TAU, GSK

The Kerus simulation tool is very powerful! The simulations for our pivotal trials showed us a suitable and straight forward path to reach marketing approval with a smaller number of patients and quicker compared to our original plans. Discussions with statistic experts from CROs, investigators and key opinion leaders confirmed the approach.

CEO, Small Biotech, Germany

“The KerusCloud platform has proved to be a core part of our decision-making as it allows us to prospectively tailor study designs as new information becomes available.”

Chief Medical Officer, BioTech, UK

“KerusCloud simulations are very intuitive. You can have a quick understanding of what the goals are, what the outputs could be, and it enables quick decision-making from the whole team regardless of their statistical background.”

Chief Scientific Officer, Pharmaceutical company, USA

“KerusCloud really helped us to design our protocol for a platform study, by using the evidence generated in our earlier exploratory phase studies to populate a model and quantitatively evaluate different design questions to not just our asset, but the evolving landscape of the disease.”

Chief Medical Officer, Biotech, Norway

“Exploristics have a well-considered and layered approach to security that exceeds our expectations. It is clear that Exploristics has invested in Operational Excellence, promoting best practice development processes.”

Roger Wallace, Head of Data, Anaeko, UK